Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisions of secondary prevention trials and their meta-analyses

MLA

Hennekens, Charles H., et al. “Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease: Randomized and Observational Comparisions of Secondary Prevention Trials and Their Meta-Analyses.” Archives of Internal Medicine, vol. 164, no. 1, Jan. 2004, p. 40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.121648612&authtype=sso&custid=ns315887.

APA

Hennekens, C. H., Sacks, F. M., Tonkin, A., Jukema, J. W., Byington, R. P., Pitt, B., Berry, D. A., Berry, S. M., Ford, N. F., Walker, A. J., Natarajan, K., Chen Sheng-Lin, Fiedorek, F. T., & Belder, R. (2004, January 12). Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisions of secondary prevention trials and their meta-analyses. Archives of Internal Medicine, 164(1), 40.

Chicago

Hennekens, Charles H., Frank M. Sacks, Andrew Tonkin, J. Wouter Jukema, Robert P. Byington, Bertram Pitt, Donald A. Berry, et al. 2004. “Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease: Randomized and Observational Comparisions of Secondary Prevention Trials and Their Meta-Analyses.” Archives of Internal Medicine, January 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.121648612&authtype=sso&custid=ns315887.